<DOC>
	<DOCNO>NCT00563797</DOCNO>
	<brief_summary>The objective study evaluate efficacy mecamylamine ( MEC , 10 mg/day ) versus placebo reduce depressive alcohol symptom patient depression co-morbid alcohol dependence . The researcher hypothesize MEC significantly reduce depressive symptom decrease alcohol consumption compare placebo patient depression alcohol dependence stable dose selective serotonin reuptake inhibitor ( SSRI ) .</brief_summary>
	<brief_title>Mecamylamine Treatment Patients With Depression Alcohol Dependence</brief_title>
	<detailed_description>Depression co-morbid alcohol dependence prevalent costly treat . The co occurrence two disorder lead great severity bad long-term outcome , include suicide . Although number treatment strategy implement depressed patient alcohol dependence controversy concern best treatment option patient persists . The clinical relationship depression alcohol dependence suggest common mechanism underlie disorder . It hypothesize medication block presynaptic nAChR may effective treatment alcoholism depression . Mecamylamine ( Inversine Â® ) noncompetitive , high affinity nAChR antagonist low selectivity alpha-7 receptor . Mecamylamine never investigate effective adjunct treatment dually diagnose patient depression alcohol dependence . Methods : Thirty participant current diagnosis depression alcohol dependence recruit 12-week treatment study . Fifteen participant randomize mecamylamine fifteen placebo . Participants include study : meet current DSM-IV criterion Major Depression Alcohol Dependence stable SSRI dose 2 week . All participant come weekly take medication complete weekly assessment . Weekly assessment consist questioner assess depressive symptom alcohol consumption entire treatment period . Significance : This study first evaluate efficacy mecamylamine augment agent treatment depression alcohol dependence .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Mecamylamine</mesh_term>
	<criteria>1 . Individuals DSMIV diagnosis Major Depression ( MD ) Alcohol Dependence ( AD ) ( use SCID ) . 2 . Individuals stable SSRI dose 2 week . 3 . Smokers nonsmoker ( smoker define smoke 5 cigarette per day ) . 4 . Individuals history substance dependence ( alcohol , tobacco cocaine ) meet criterion substance dependence past 30 day include ( use SCID ) . 5 . Women childbearing potential must negative pregnancy test use acceptable method contraception . 6 . Individuals able participate psychologically physically ; give informed consent ; complete assessment ; take study medication ; otherwise participate trial . A postconsent test give assess patient 's capacity give inform consent . 1 . Females pregnant lactating . 2 . Patients may take medication think influence drinking behavior , include : acamprosate , disulfiram , naltrexone , ondansetron . 3 . Patients significant underlying medical condition , cerebral , renal , thyroid , hepatic cardiac pathology , opinion physician would preclude patient fully cooperate potential harm course study . 4 . Patients history glaucoma , prostatic hypertrophy , urethral obstruction , cerebral arteriosclerosis , pyloric stenosis , history hypersensitivity mecamylamine . 5 . Patients meet current SCID criterion follow major Axis I diagnosis ( Posttraumatic Stress Disorders ( PTSD ) , Bipolar Disorders , Schizophrenia Schizophreniatype Disorders ) . 6 . Patients current unstable medical condition neurological , cardiovascular , endocrine , renal , liver , thyroid pathology ( LFT 5 time normal , abnormal BUN creatinine , unmanaged hypertension BP high 200/120 ) . 7 . Patients pharmacological treatment alcohol and/or nicotine dependence . ( 8 ) Patients take bethanechol . ( 9 ) Patients risk suicide .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>treatment</keyword>
	<keyword>alcohol dependence</keyword>
	<keyword>depression</keyword>
	<keyword>mecamylamine</keyword>
</DOC>